Molecular Partners Ag (MOLN) Cash from Investing Activities (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Cash from Investing Activities for 7 consecutive years, with -$5016.1 the latest figure, recorded in Q1 2026.

• Quarterly Cash from Investing Activities fell 112.9% year-over-year to -$5016.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88.6 million (up 98.04% YoY) and the FY2025 annual result came in at $90.8 million, up 96.41% from the prior year.
• Cash from Investing Activities slipped to -$5016.1 in Q1 2026 per MOLN's latest filing, from $90.7 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for MOLN reached as high as $113.3 million in Q3 2022 and fell as low as -$113.7 million in Q2 2022.
• A 5-year average of $4.6 million and a median of $20176.6 in 2024 frame the typical range for Cash from Investing Activities.
• The largest YoY upside for Cash from Investing Activities was 1175.75% in 2022 against a maximum downside of 22331.61% in 2022.
• Year by year, Cash from Investing Activities stood at -$104.8 million in 2022, then surged by 147.98% to $50.3 million in 2023, then dropped by 8.21% to $46.2 million in 2024, then surged by 96.46% to $90.7 million in 2025, then slumped by 100.01% to -$5016.1 in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$5016.1, $90.7 million, and -$62.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.